Natural products targeting diabetes vary in valueWhile products in question seem safe, not all boast effectiveness. Rethinking breast cancer How to tackle no-shows Study finds no difference in adjuvant therapy strategies Continuous aromatase inhibitor therapy no better than starting with tamoxifen Vyvanse for ADHD Celebrating a doctor’s well-spent life Intensive type 2 diabetes treatment fraught with danger Low HbA1c levels and insulin-based therapy are linked with increased mortality in British database Statins benefit leukemia patients Clinical trials needed to pinpoint ideal candidates Adjuvant therapy has feverish results in real-world care Febrile neutropenia observed at higher than expected rate Poorer women have lower epidural rates Canadian study reveals treatment disparities according to socioeconomic and educational status First Previous 2126 2127 2128 2129 2130 Next Last
